UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Association of MRI metrics and cognitive impairment in radiologically isolated syndromes

Neurology, 2012-01, Vol.78 (5), p.309-314

2012

Volltextzugriff (PDF)

Prevalence of patient-reported dysphagia in multiple sclerosis patients: An Italian multicenter study (using the DYMUS questionnaire)

Journal of the neurological sciences, 2013-08, Vol.331 (1), p.94-97

2013

Volltextzugriff (PDF)

Functional and structural disruption of the precuneus contributes to cognitive impairment in pediatric multiple sclerosis

Journal of the neurological sciences, 2013-10, Vol.333, p.e386-e386

2013

Volltextzugriff (PDF)

Post-marketing of disease modifying drugs in multiple sclerosis: An exploratory analysis of gender effect in interferon beta treatment

Journal of the neurological sciences, 2009-11, Vol.286 (1), p.109-113

2009

Volltextzugriff (PDF)

Cognitive and psychosocial features in childhood and juvenile MS: two-year follow-up

Neurology, 2010-09, Vol.75 (13), p.1134-1140

2010

Volltextzugriff (PDF)

Breastfeeding is not related to postpartum relapses in multiple sclerosis

Neurology, 2011-07, Vol.77 (2), p.145-150

2011

Volltextzugriff (PDF)

Costi sociali e aspetti farmacoeconomici

1. Aufl., 2005

Volltextzugriff (PDF)

Cortical lesions in radiologically isolated syndrome

Neurology, 2011-11, Vol.77 (21), p.1896-1899

2011

Volltextzugriff (PDF)

Long-term safety and efficacy of teriflunomide: Nine-year follow-up of the randomized TEMSO study

Neurology, 2016-03, Vol.86 (10), p.920-930

2016

Volltextzugriff (PDF)

Pregnancy and fetal outcomes after interferon-β exposure in multiple sclerosis

Neurology, 2010-11, Vol.75 (20), p.1794-1802

2010

Volltextzugriff (PDF)

FP21-TU-03 Serum N-acetyl aspartate (NAA) levels differ in multiple sclerosis (MS) and neuromyelitis optica (NMO)

Journal of the neurological sciences, 2009, Vol.285, p.S90-S90

2009

Volltextzugriff (PDF)

PGI23 Treatments in Neurogenic Bowel Dysfunctions: Clinical Recommendations in Adults

Value in health, 2020-12, Vol.23, p.S537-S537

2020

Volltextzugriff (PDF)

Peak width of skeletonized mean diffusivity (PSMD) and cognitive functions in relapsing-remitting multiple sclerosis

Brain imaging and behavior, 2021-08, Vol.15 (4), p.2228-2233

2021

Volltextzugriff (PDF)

Quality of life in multiple sclerosis: the impact of depression, fatigue and disability

Multiple sclerosis, 2001-10, Vol.7 (5), p.340-344

2001

Volltextzugriff (PDF)

FP39-WE-05 High incidence of acute leukaemia in multiple sclerosis patients treated with mitoxantrone: a retrospective multicentre Italian study

Journal of the neurological sciences, 2009, Vol.285, p.S120-S120

2009

Volltextzugriff (PDF)

Real-life impact of early interferonβ therapy in relapsing multiple sclerosis

Annals of neurology, 2009-10, Vol.66 (4), p.513-520

2009

Volltextzugriff (PDF)

Acute myeloid leukemia in Italian patients with multiple sclerosis treated with mitoxantrone

Neurology, 2011-11, Vol.77 (21), p.1887-1895

2011

Volltextzugriff (PDF)

Long-Term Adherence to Interferon β Therapy in Relapsing-Remitting Multiple Sclerosis

European neurology, 2008-01, Vol.59 (3-4), p.131-135

2008

Volltextzugriff (PDF)

Factors associated with treatment escalation among MS specialists and general neurologists: Results from an International cojoint study

Multiple sclerosis and related disorders, 2022-02, Vol.58, p.103404-103404, Article 103404

2022

Volltextzugriff (PDF)

The clinical spectrum of anti-MOG associated acquired demyelinating disorders: Three case-reports

Multiple sclerosis and related disorders, 2019-08, Vol.33, p.51-54

2019

Volltextzugriff (PDF)

Caregiver quality of life in multiple sclerosis: a multicentre Italian study

Multiple sclerosis, 2007-04, Vol.13 (3), p.412-419

2007

Volltextzugriff (PDF)

Autologous hematopoietic stem cell transplantation for very active relapsing-remitting multiple sclerosis: report of two cases

Multiple sclerosis, 2007-06, Vol.13 (5), p.676-678

2007

Volltextzugriff (PDF)

Switching to Second-Line Therapies in Interferon-Beta-Treated Relapsing-Remitting Multiple Sclerosis Patients

European neurology, 2009-01, Vol.61 (3), p.177-182

2009

Volltextzugriff (PDF)

A double blind, placebo-controlled, phase II, add-on study of cyclophosphamide (CTX) for 24 months in patients affected by multiple sclerosis on a background therapy with interferon-beta study denomination: CYCLIN

Journal of the neurological sciences, 2004-08, Vol.223 (1), p.69-71

2004

Volltextzugriff (PDF)

European validation of a standardized clinical description of multiple sclerosis

Journal of neurology, 2004-12, Vol.251 (12), p.1472-1480

2004

Volltextzugriff (PDF)

1 – 25 von 54

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(41)
Mit Volltextzugriff
(45)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Association of MRI metrics and cognitive impairment in radiologically isolated syndromes

Prevalence of patient-reported dysphagia in multiple sclerosis patients: An Italian multicenter study (using the DYMUS questionnaire)

Functional and structural disruption of the precuneus contributes to cognitive impairment in pediatric multiple sclerosis

Post-marketing of disease modifying drugs in multiple sclerosis: An exploratory analysis of gender effect in interferon beta treatment

Cognitive and psychosocial features in childhood and juvenile MS: two-year follow-up

Breastfeeding is not related to postpartum relapses in multiple sclerosis

Costi sociali e aspetti farmacoeconomici

Cortical lesions in radiologically isolated syndrome

Long-term safety and efficacy of teriflunomide: Nine-year follow-up of the randomized TEMSO study

Pregnancy and fetal outcomes after interferon-β exposure in multiple sclerosis

FP21-TU-03 Serum N-acetyl aspartate (NAA) levels differ in multiple sclerosis (MS) and neuromyelitis optica (NMO)

PGI23 Treatments in Neurogenic Bowel Dysfunctions: Clinical Recommendations in Adults

Peak width of skeletonized mean diffusivity (PSMD) and cognitive functions in relapsing-remitting multiple sclerosis

Quality of life in multiple sclerosis: the impact of depression, fatigue and disability

FP39-WE-05 High incidence of acute leukaemia in multiple sclerosis patients treated with mitoxantrone: a retrospective multicentre Italian study

Real-life impact of early interferonβ therapy in relapsing multiple sclerosis

Acute myeloid leukemia in Italian patients with multiple sclerosis treated with mitoxantrone

Long-Term Adherence to Interferon β Therapy in Relapsing-Remitting Multiple Sclerosis

Factors associated with treatment escalation among MS specialists and general neurologists: Results from an International cojoint study

The clinical spectrum of anti-MOG associated acquired demyelinating disorders: Three case-reports

Caregiver quality of life in multiple sclerosis: a multicentre Italian study

Autologous hematopoietic stem cell transplantation for very active relapsing-remitting multiple sclerosis: report of two cases

Switching to Second-Line Therapies in Interferon-Beta-Treated Relapsing-Remitting Multiple Sclerosis Patients

A double blind, placebo-controlled, phase II, add-on study of cyclophosphamide (CTX) for 24 months in patients affected by multiple sclerosis on a background therapy with interferon-beta study denomination: CYCLIN

European validation of a standardized clinical description of multiple sclerosis

Suchergebnisse filtern